Re: US 2017 Tax Cuts and Jobs Act
|
2
|
Resverlogix Corp.
|
Dec 21, 2017 08:52PM
|
Re: Zenith
|
2
|
Resverlogix Corp.
|
Nov 04, 2019 10:43AM
|
Re: Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Jan 11, 2018 04:39PM
|
Re: Who'd a thunk....
|
2
|
Resverlogix Corp.
|
Oct 17, 2019 07:53PM
|
Re: Just got off the phone with my brokerage...this might be interesting
|
2
|
Resverlogix Corp.
|
Apr 22, 2019 12:32PM
|
Re: Clarification on BETonMACE baseline data
|
2
|
Resverlogix Corp.
|
Sep 04, 2019 02:41PM
|
Re: Interesting read on the backlash to FDA's approval of aducanumab
|
2
|
Resverlogix Corp.
|
Jun 10, 2021 08:35PM
|
Re: That was one sweet day of trading....
|
2
|
Resverlogix Corp.
|
Aug 02, 2018 09:53AM
|
Re: why on earth
|
2
|
Resverlogix Corp.
|
May 13, 2024 03:55PM
|
Re: RVXs up or down draft from ZENE???
|
2
|
Resverlogix Corp.
|
Jan 11, 2024 12:35AM
|
Re: Just got off the phone with my brokerage...this might be interesting
|
2
|
Resverlogix Corp.
|
Apr 22, 2019 12:43PM
|
Re: Gilead's GS-5829 flops in mCRPC
|
2
|
Zenith Epigenetics
|
Jul 19, 2022 04:42PM
|
Re: WHY
|
2
|
Resverlogix Corp.
|
Oct 10, 2019 01:16PM
|
Re: Questions about units
|
2
|
Resverlogix Corp.
|
May 17, 2019 11:23AM
|
Re: Groundwork for Future Trials
|
2
|
Resverlogix Corp.
|
Oct 02, 2019 03:48PM
|
Re: Anyways Gran Oso.....
|
2
|
Resverlogix Corp.
|
Jul 31, 2019 09:42PM
|
Re: Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
2
|
Resverlogix Corp.
|
Aug 05, 2017 02:25AM
|
Re: No update yet from stockwatch....
|
2
|
Resverlogix Corp.
|
Jun 06, 2018 02:30PM
|
Re: Total Shares Outstanding 10/15/20
|
2
|
Resverlogix Corp.
|
Oct 16, 2020 05:21PM
|
Re: Breakthrough Therapy Designation
|
2
|
Resverlogix Corp.
|
Jun 13, 2023 12:26PM
|